Compare AU
Compare IZZ vs. EDOC
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the FTSE China 50 (IZZ) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IZZ | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 32 | 10 |
Median incremental investment | $2,600.00 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,026.51 | $624.97 |
Average age group | > 35 | > 35 |
Key Summary
IZZ | EDOC | |
|---|---|---|
Strategy | IZZ.AX was created on 2004-10-05 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 376.32m in AUM and 50 holdings. The fund aims to provide investors with the performance of the FTSE China 50 Index, before fees and expenses. The index is designed to measure the performance of 50 of the largest and most liquid Chinese companies which trade on the Hong Kong Stock Exchange | EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | MEITUAN (10.47 %) ALIBABA GROUP HOLDING LTD (8.86 %) TENCENT HOLDINGS LTD (8.29 %) | INSULET CORP (8.47 %) BOSTON SCIENTIFIC CORP (8.24 %) ABBOTT LABORATORIES (7.76 %) |
Top 3 industries | Other (58.33 %) Consumer Discretionary (21.66 %) Communication Services (10.44 %) | Health Care (75.06 %) Other (24.70 %) Consumer Staples (14.33 %) |
Top 3 countries | China (100.00 %) | United States (77.51 %) China (13.32 %) Japan (4.67 %) |
Management fee | 0.74 % | 0.67 % |
Key Summary
IZZ | EDOC | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | FTSE China 50 Net Tax USD Index | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.74 % | 0.67 % |
Price | $49.71 | $10.33 |
Size | $338.261 million | $1.525 million |
10Y return | 1.78 % | N/A |
Annual distribution yield (5Y) | 1.97 % | - % |
Market | ASX | ASX |
First listed date | 15/11/2007 | 29/03/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IZZ | EDOC | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 32 | 10 |
Median incremental investment | $2,600.00 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,026.51 | $624.97 |
Average age group | > 35 | > 35 |
Pros and Cons
IZZ | EDOC | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IZZ | EDOC |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |